Afry AB
STO:AFRY
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
145.8
201.6
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
AFRY
stock under the Base Case scenario is
257.09
SEK.
Compared to the current market price of 148.6 SEK,
Afry AB
is
Undervalued by 42%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Afry AB.
| UK |
|
Relx PLC
LSE:REL
|
|
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
|
| UK |
I
|
IHS Markit Ltd
F:0M3
|
|
| IE |
|
Experian PLC
LSE:EXPN
|
|
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
|
| US |
|
Equifax Inc
NYSE:EFX
|
|
| US |
|
CoStar Group Inc
NASDAQ:CSGP
|
|
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
|
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
|
| CH |
|
SGS SA
SIX:SGSN
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Afry AB
Balance Sheet Decomposition
Afry AB
| Current Assets | 9.5B |
| Cash & Short-Term Investments | 756m |
| Receivables | 4B |
| Other Current Assets | 4.7B |
| Non-Current Assets | 17.5B |
| PP&E | 1.5B |
| Intangibles | 15.6B |
| Other Non-Current Assets | 399m |
| Current Liabilities | 7.8B |
| Accounts Payable | 867m |
| Other Current Liabilities | 6.9B |
| Non-Current Liabilities | 6.7B |
| Long-Term Debt | 6B |
| Other Non-Current Liabilities | 648m |
Free Cash Flow Analysis
Afry AB
| SEK | |
| Free Cash Flow | SEK |
Earnings Waterfall
Afry AB
|
Revenue
|
26.2B
SEK
|
|
Cost of Revenue
|
-5.4B
SEK
|
|
Gross Profit
|
20.8B
SEK
|
|
Operating Expenses
|
-19.3B
SEK
|
|
Operating Income
|
1.6B
SEK
|
|
Other Expenses
|
-621m
SEK
|
|
Net Income
|
929m
SEK
|
AFRY Profitability Score
Profitability Due Diligence
Afry AB's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Afry AB's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
AFRY Solvency Score
Solvency Due Diligence
Afry AB's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Afry AB's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AFRY Price Targets Summary
Afry AB
According to Wall Street analysts, the average 1-year price target for
AFRY
is 209.1 SEK
with a low forecast of 166.65 SEK and a high forecast of 252 SEK.
Dividends
Current shareholder yield for
AFRY is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AFRY
stock under the Base Case scenario is
257.09
SEK.
Compared to the current market price of 148.6 SEK,
Afry AB
is
Undervalued by 42%.